Trial Profile
Clinical Trials Insight: 700060707
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2010
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 29 Oct 2010 New trial record
- 25 Sep 2010 Results were reported at the 2010 Breast Cancer Symposium.